The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-[(E)-but-2-enyl]-2-methyl-4-[4-(morpholine-4-carbonyl)phenyl]-1H-pyrrolo[2,3-c]pyridin-7-one ID: ALA5284261
Max Phase: Preclinical
Molecular Formula: C23H25N3O3
Molecular Weight: 391.47
Associated Items:
Names and Identifiers Canonical SMILES: C/C=C/Cn1cc(-c2ccc(C(=O)N3CCOCC3)cc2)c2cc(C)[nH]c2c1=O
Standard InChI: InChI=1S/C23H25N3O3/c1-3-4-9-26-15-20(19-14-16(2)24-21(19)23(26)28)17-5-7-18(8-6-17)22(27)25-10-12-29-13-11-25/h3-8,14-15,24H,9-13H2,1-2H3/b4-3+
Standard InChI Key: POICMTYCJMMADL-ONEGZZNKSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
-0.3340 2.4739 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3805 2.8862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0924 2.4744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0924 1.6491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3822 1.2374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3340 1.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3822 0.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0968 -0.0005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0961 -0.8232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3812 -1.2359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3306 -0.8268 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3353 -0.0020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3812 -2.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0959 -2.4737 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -2.4737 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3333 -3.2989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0479 -3.7115 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7625 -3.2989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.7626 -2.4737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0479 -2.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8753 1.4033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3673 2.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8966 2.7245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3805 3.7115 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0486 2.8866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7633 2.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4779 2.8866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1925 2.4739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1925 2.0709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
7 5 1 0
8 7 2 0
9 8 1 0
10 9 2 0
11 10 1 0
12 11 2 0
7 12 1 0
10 13 1 0
13 14 2 0
13 15 1 0
16 15 1 0
17 16 1 0
18 17 1 0
19 18 1 0
20 19 1 0
15 20 1 0
4 21 1 0
21 22 2 0
23 22 1 0
3 23 1 0
2 24 2 0
1 25 1 0
25 26 1 0
26 27 2 0
27 28 1 0
22 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 391.47Molecular Weight (Monoisotopic): 391.1896AlogP: 3.35#Rotatable Bonds: 4Polar Surface Area: 67.33Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.85CX Basic pKa: ┄CX LogP: 2.38CX LogD: 2.38Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.69Np Likeness Score: -0.98
References 1. Crawford TD, Vartanian S, Côté A, Bellon S, Duplessis M, Flynn EM, Hewitt M, Huang HR, Kiefer JR, Murray J, Nasveschuk CG, Pardo E, Romero FA, Sandy P, Tang Y, Taylor AM, Tsui V, Wang J, Wang S, Zawadzke L, Albrecht BK, Magnuson SR, Cochran AG, Stokoe D.. (2017) Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance., 27 (15): [PMID:28606761 ] [10.1016/j.bmcl.2017.05.063 ]